AOD-9604 did not affect blood sugar levels, did not cause insulin resistance, and did not produce the antibody responses that can develop with growth hormone therapy
Avoid use in dogs with Carprofen hypersensitivity, cats, pregnant or lactating dogs, or those under 4 months
Safety and Clinical Supervision Though the BPC-157 peptide is not FDA-approved for general medical use, there is ample evidence showcasing its effectiveness
These include inflammation modulation, angiogenesis, collagen organization, cell migration, gut barrier support, and tissue remodeling
TB-500, a synthetic fragment of Thymosin Beta-4, regulates actin polymerization and F-actin formation